Education
About Us
Working with TipRanks
Follow Us
Altimmune (GB:0A4C)
:0A4C
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 20.00K | $ 426.00K | $ -68.00K | $ 4.41M | $ 8.19M |
| Gross Profit | $ 20.00K | $ -51.00K | $ -136.00K | $ 3.86M | $ -25.32M |
| Operating Income | $ -103.17M | $ -95.93M | $ -87.74M | $ -96.91M | $ -54.80M |
| EBITDA | $ -94.81M | $ -87.94M | $ -84.40M | $ -96.53M | $ -54.15M |
| Net Income | $ -95.06M | $ -88.45M | $ -84.71M | $ -96.17M | $ -49.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 131.89M | $ 197.81M | $ 184.88M | $ 190.30M | $ 215.92M |
| Total Assets | $ 139.31M | $ 210.64M | $ 206.93M | $ 218.86M | $ 245.12M |
| Total Debt | $ 1.68M | $ 671.00K | $ 1.12M | $ 1.54M | $ 1.82M |
| Net Debt | $ -35.24M | $ -134.45M | $ -109.97M | $ -188.77M | $ -114.09M |
| Total Liabilities | $ 15.80M | $ 16.54M | $ 21.64M | $ 19.73M | $ 19.24M |
| Stockholders' Equity | $ 123.51M | $ 194.10M | $ 185.29M | $ 199.13M | $ 225.88M |
| Cash Flow | |||||
| Free Cash Flow | $ -79.85M | $ -75.86M | $ -62.71M | $ -90.55M | $ -34.78M |
| Operating Cash Flow | $ -79.85M | $ -75.81M | $ -62.59M | $ -78.24M | $ -34.44M |
| Investing Cash Flow | $ -28.39M | $ 13.73M | $ -73.40M | $ 87.52M | $ -72.09M |
| Financing Cash Flow | $ 10.04M | $ 86.11M | $ 56.78M | $ 65.10M | $ 213.49M |